COMMUNIQUÉS West-GlobeNewswire

argenx to host KOL breakfast symposium on pemphigus vulgaris on November 10, 2017

02/11/2017 - 07:00

November 2, 2 017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

MDxHealth Nine Month Trading Update

02/11/2017 - 07:00

Patient test volume for the first nine months up 43% SelectMDx test volume in Europe increased nearly 400% NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, November [...]

Rapport d'activités des neuf premiers mois de MDxHealth

02/11/2017 - 07:00

Le volume des tests pour les patients a augmenté de 43 % les neuf premiers mois Le volume des tests SelectMDx en Europe a augmenté de près de 400 % COMMUNIQUÉ DE PRESSE / INFORMATION RÉGLEMENTÉE / INFORMATION [...]

TiGenix strengthens European IP protection around lead development program Cx601

02/11/2017 - 07:00

PRESS RELEASE TiGenix strengthens European IP protection around lead development program Cx601 Leuven (BELGIUM) - November 2, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced [...]

TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601

02/11/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601 Louvain (BELGIQUE) - 2 novembre 2017, 07h. CET - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]

Targovax ASA: Third quarter 2017 results

02/11/2017 - 07:00

Oslo, Norway, 2 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its third quarter 2017 results. A meeting for [...]

Orion Corporation: Managers' transactions - Hilpi Rautelin

01/11/2017 - 21:15

ORION CORPORATION MANAGERS' TRANSACTIONS 1 st of November 2017 at 22.15 EET Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse [...]

Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference

01/11/2017 - 21:05

DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Medtronic Unveils Strong Early Outcomes for the Intrepid(TM) Transcatheter Mitral Valve Replacement (TMVR) System

01/11/2017 - 19:15

First Report Investigation at TCT Published in JACC Shows Substantial Mitral Valve Regurgitation Reductions and Versatility of Dual-Stent Design DUBLIN and DENVER - November 1, 2017 - Medtronic plc (NYSE:MDT) today [...]

Independent Study Shows New Data on Shortened DAPT in STEMI Patients with Medtronic Resolute Integrity Drug-Eluting Stent

01/11/2017 - 18:20

DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI [...]

Shire plc : Director/PDMR Shareholding

01/11/2017 - 16:00

Director/PDMR Shareholding November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH

01/11/2017 - 14:17

Heidelberg, Germany, November 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that the [...]

uniQure Announces Presentations at the 59th American Society of Hematology (ASH) Annual Meeting

01/11/2017 - 14:10

~ New Nonclinical Data on AMT-061 to be Presented Saturday, December 9, 2017 ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy [...]

Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease

01/11/2017 - 14:05

Primary results of pivotal Kymriah TM Phase II JULIET study in relapsed/refractory DLBCL Post-hoc sub-analysis of crizanlizumab (SEG101, formerly SelG1) SUSTAIN trial evaluating time to first sickle cell pain crisis [...]

Inivata Announces Strategic Partnership with West Cancer Center

01/11/2017 - 13:30

Inivata Announces Strategic Partnership with West Cancer Center West Cancer Center joins the Inivata Knowledge Accumulation Network (IKAN) Research Triangle Park, NC and Cambridge, UK, November 1, 2017 -- Inivata , a [...]

Align Technology Ongoing Support of Orthodontic and Dental Research

01/11/2017 - 13:30

2018 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, CA--(Marketwired - November 01, 2017) - Align Technology, Inc. (NASDAQ: ALGN ) today announced the opening of its 2018 Research Award [...]

Shire plc : Total voting rights

01/11/2017 - 13:00

Total Voting Rights November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]

EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017

01/11/2017 - 12:30

Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital Conference Call to Review Results to be [...]

uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress

01/11/2017 - 12:00

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]